Agencies Are Not Maximizing Opportunities for Competition or Savings under Blanket Purchase Agreements despite Significant Increase in Usage

October 2009
GAO Reports;10/9/2009, preceding p1
Government Document
The article presents the September 2009 report of the U.S. Government Accountability Office (GAO) to the Committee on Oversight and Government Reform, House of Representatives concerning contract management of the country. It discusses the usage of civilian agencies on the schedule blanket purchase agreements (BPAs) for services and the receive discounts from schedule pricing. It also highlights the procedures and discounts in instituting schedule BPAs.


Related Articles

  • Contract Management: Opportunities Continue for GSA to Improve Pricing of Multiple Award Schedules Contracts: GAO-05-911T. Cooper, David E. // GAO Reports;7/26/2005, p1 

    Each year, federal agencies spend billions of dollars to buy commercial products and services through the General Service Administration's (GSA) Multiple Award Schedules program. The program has grown significantly over the past several years. Currently, federal agencies can directly purchase,...

  • GAO reports extraordinary price hikes on brandname drug products.  // PharmacoEconomics & Outcomes News;1/23/2010, Issue 595, p11 

    The article focuses on a report from the U.S. Government Accountability Office (GAO) which revealed that there were 416 brand name drug products that had price increases of greater than 100% between 2000 and 2008.

  • GAO Blames Exclusivity for Drug Price Hikes.  // Pharmaceutical Representative;Feb2010, Vol. 40 Issue 2, p8 

    The article reports that the Government Accountability Office (GAO) has released a document explaining the relation between drug pricing and decreased competition in the U.S.

  • Subject: Initial Results on Availability of Terrorism Insurance in Specific Geographic Markets.  // GAO Reports;7/11/2008, p1 

    The article presents the initial results on availability of terrorism insurance in specific geographic markets addressed by the U.S. Government Accountability Office. Accordingly, GAO complied and analyzed the available data on insurance and reinsurance industry capacity, terrorism insurance...

  • Gov't finds sharp price increases in drugs. M. A. // Medical Marketing & Media;Feb2010, Vol. 45 Issue 2, p9 

    The article reports on the U.S. Government Accountability Office (GAO) study which found extraordinary price increases, which are those of over 100 percent at a single point in time, in branded drug products.

  • Report spurs calls to end price secrecy for medical devices. Pecquet, Julian // Hill;2/7/2012, Vol. 19 Issue 15, p15 

    The article reports on the increasing calls over price transparency for medical devices which are stimulated by a report from the U.S. Government Accountability Office (GAO) which concludes the limited ability of hospitals to negotiate the best price for medical devices.

  • Actions Needed to Ensure Value for Service Contracts.  // GAO Reports;4/23/2009, preceding p1 

    The article offers information on the research conducted by the U.S. Government Accountability Office (GAO) which examines the value of services contracts of the Department of Defense (DOD). GAO examines challenges faced by DOD in following sound contract and contracting management practices and...

  • Reforms to the DCCA: The Potential Effect on Contract Management. HORAN, JACK // Contract Management;Dec2009, Vol. 49 Issue 12, p92 

    The article discusses the impact of the reforms to the Defense Contract Audit Agency (DCAA) audit quality on contract management in the U.S. The Government Accountability Office (GAO) reported that DCAA was a failure and recommended changes in DCAA's goals and management. GAO aims to increase...

  • GAO: CMS contract controls deficient. McCarty, Mark // Medical Device Daily;12/2/2009, Vol. 13 Issue 231, p5 

    The article investigates the management of contracts for various programs by Consultant Management Systems including the Part D prescription drug benefit, Medicaid and the State Children's Health Insurance Program, which the U.S. Government Accountability Office found deficient of contract controls.


Read the Article

Other Topics